Litcius/Paper detail

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Maximilian F. Konig, Alfred H.J. Kim, Marc H. Scheetz, Elizabeth R. Graef, Jean W Liew, Julia F. Simard, Pedro Machado, Milena Gianfrancesco, Jinoos Yazdany, Daman Langguth, Philip C. Robinson

2020Annals of the Rheumatic Diseases83 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHydroxychloroquineRetrospective cohort studySurgeryCholecystitisCholecystectomyGeneral surgeryLaparoscopic surgeryLaparoscopyCoronavirus disease 2019 (COVID-19)Internal medicineGallbladderInfectious disease (medical specialty)DiseaseCOVID-19 and healthcare impactsHematological disorders and diagnosticsDiversity and Career in Medicine
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 | Litcius